Cargando…
Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
The ongoing COVID-19 pandemic caused by the coronavirus, SARS-CoV-2, has already caused in excess of 1.25 million deaths worldwide, and the number is increasing. Knowledge of the host transcriptional response against this virus and how the pathways are activated or suppressed compared to other human...
Autores principales: | Krishnamoorthy, Pandikannan, Raj, Athira S., Roy, Swagnik, Kumar, Nachimuthu Senthil, Kumar, Himanshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683955/ https://www.ncbi.nlm.nih.gov/pubmed/33260034 http://dx.doi.org/10.1016/j.compbiomed.2020.104123 |
Ejemplares similares
-
Identification of gene classifier and modules associated with SARS-CoV-2 ARI in nasal swab
por: Krishnamoorthy, Pandikannan, et al.
Publicado: (2023) -
Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021) -
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022) -
Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome
using MEGA
por: Sohpal, Vipan Kumar
Publicado: (2020) -
Comparative study: nonsynonymous and synonymous substitution of SARS-CoV-2, SARS-CoV, and MERS-CoV genome
por: Sohpal, Vipan Kumar
Publicado: (2021)